12 results
8-K
EX-99.1
LYEL
Lyell Immunopharma, Inc.
8 Aug 23
Lyell Immunopharma Reports Business Highlights and Financial Results for the Second Quarter 2023
4:10pm
builder who has successfully led growth in complex organizations. Mr. Lang is responsible for Lyell’s legal, compliance, human resources, alliance
DEF 14A
mchpa4ylceirk0aect
28 Apr 22
Definitive proxy
4:11pm
424B4
ze42i
18 Jun 21
Prospectus supplement with pricing info
12:00am
S-1/A
6n1mvqgdz4s
9 Jun 21
IPO registration (amended)
7:12am
S-1
h59r4 vxcsy
25 May 21
IPO registration
5:28pm
DRS/A
3y8f33cs0xyy 2fieqw
12 May 21
Draft registration statement (amended)
12:00am
DRS
zljtswuh
12 Apr 21
Draft registration statement
12:00am
- Prev
- 1
- Next